Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China
· Delayed Price · Currency is CNY 5.23
+0.22 (4.39%)
Jun 6, 2025, 2:45 PM CST
SHA:603669 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 342.79 | 369.53 | 189.31 | 281.79 | 734.89 | 1,000 | Upgrade
|
| Other Revenue | 10.25 | 10.25 | 7.52 | 7.47 | 5.43 | 0.66 | Upgrade
|
| Revenue | 353.04 | 379.78 | 196.83 | 289.26 | 740.33 | 1,001 | Upgrade
|
| Revenue Growth (YoY) | 76.18% | 92.95% | -31.95% | -60.93% | -26.04% | -38.78% | Upgrade
|
| Cost of Revenue | 209.59 | 206.52 | 109.88 | 94.53 | 155.71 | 165.49 | Upgrade
|
| Gross Profit | 143.45 | 173.26 | 86.96 | 194.74 | 584.62 | 835.51 | Upgrade
|
| Selling, General & Admin | 191.53 | 230.78 | 213.48 | 327.1 | 513.55 | 698.76 | Upgrade
|
| Research & Development | 25.7 | 26.66 | 29.12 | 31.63 | 22.77 | 20.36 | Upgrade
|
| Other Operating Expenses | 10.57 | 4.79 | 5.02 | 6.3 | 9.61 | 13.33 | Upgrade
|
| Operating Expenses | 250.73 | 282.53 | 256.94 | 371.78 | 546.2 | 732.84 | Upgrade
|
| Operating Income | -107.28 | -109.27 | -169.99 | -177.04 | 38.42 | 102.66 | Upgrade
|
| Interest Expense | -32.28 | -27.38 | -3.71 | -5.83 | -15.51 | -11.25 | Upgrade
|
| Interest & Investment Income | 0.85 | 1.29 | 3.31 | 7.11 | 25.31 | 8.12 | Upgrade
|
| Other Non Operating Income (Expenses) | 24.98 | 26 | -0.81 | -0.31 | -2.41 | -1.63 | Upgrade
|
| EBT Excluding Unusual Items | -113.73 | -109.35 | -171.2 | -176.08 | 45.81 | 97.9 | Upgrade
|
| Impairment of Goodwill | - | - | - | -2.03 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -11.98 | -14.75 | -14.53 | -14.11 | 0.85 | -5.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.32 | -2.24 | 0.08 | 0.45 | -0.01 | -0.03 | Upgrade
|
| Asset Writedown | -20.39 | -20.41 | -4.12 | -0.01 | -0.19 | -0.37 | Upgrade
|
| Other Unusual Items | 18.14 | 19.02 | 38.82 | 2.98 | 24.03 | 87.04 | Upgrade
|
| Pretax Income | -130.28 | -127.73 | -150.95 | -188.81 | 70.48 | 179.26 | Upgrade
|
| Income Tax Expense | 3.06 | 3.03 | 0.54 | 7.06 | 4.58 | 19.19 | Upgrade
|
| Net Income | -133.34 | -130.76 | -151.5 | -195.86 | 65.9 | 160.07 | Upgrade
|
| Net Income to Common | -133.34 | -130.76 | -151.5 | -195.86 | 65.9 | 160.07 | Upgrade
|
| Net Income Growth | - | - | - | - | -58.83% | -20.60% | Upgrade
|
| Shares Outstanding (Basic) | 676 | 721 | 721 | 720 | 718 | 728 | Upgrade
|
| Shares Outstanding (Diluted) | 676 | 721 | 721 | 720 | 718 | 762 | Upgrade
|
| Shares Change (YoY) | -7.43% | - | 0.17% | 0.18% | -5.75% | 5.87% | Upgrade
|
| EPS (Basic) | -0.20 | -0.18 | -0.21 | -0.27 | 0.09 | 0.22 | Upgrade
|
| EPS (Diluted) | -0.20 | -0.18 | -0.21 | -0.27 | 0.09 | 0.21 | Upgrade
|
| EPS Growth | - | - | - | - | -57.14% | -25.00% | Upgrade
|
| Free Cash Flow | -109.07 | -119.74 | -61.01 | -109.2 | 73.69 | 64.86 | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.17 | -0.09 | -0.15 | 0.10 | 0.09 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.100 | 0.200 | Upgrade
|
| Dividend Growth | - | - | - | - | -50.00% | -30.00% | Upgrade
|
| Gross Margin | 40.63% | 45.62% | 44.18% | 67.32% | 78.97% | 83.47% | Upgrade
|
| Operating Margin | -30.39% | -28.77% | -86.36% | -61.20% | 5.19% | 10.26% | Upgrade
|
| Profit Margin | -37.77% | -34.43% | -76.97% | -67.71% | 8.90% | 15.99% | Upgrade
|
| Free Cash Flow Margin | -30.89% | -31.53% | -30.99% | -37.75% | 9.95% | 6.48% | Upgrade
|
| EBITDA | -82.24 | -80.43 | -125.93 | -134.37 | 77.83 | 140.23 | Upgrade
|
| EBITDA Margin | -23.29% | -21.18% | -63.98% | -46.45% | 10.51% | 14.01% | Upgrade
|
| D&A For EBITDA | 25.04 | 28.84 | 44.05 | 42.67 | 39.41 | 37.56 | Upgrade
|
| EBIT | -107.28 | -109.27 | -169.99 | -177.04 | 38.42 | 102.66 | Upgrade
|
| EBIT Margin | -30.39% | -28.77% | -86.36% | -61.20% | 5.19% | 10.26% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 6.49% | 10.70% | Upgrade
|
| Revenue as Reported | 353.04 | 379.78 | 196.83 | 289.26 | 740.33 | 1,001 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.